Pepijn Vemer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pepijn Vemer

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Plos One|February 11, 2016

Cost-Analysis of Seven Nosocomial Outbreaks in an Academic HospitalJan-Willem H Dik, Ariane G Dinkelacker, Pepijn Vemer, et al.

Leukemia Research|September 23, 2016

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The NetherlandsHedwig M Blommestein, Saskia de Groot, Mieke J Aarts, et al.

Plos One|September 7, 2019

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic reviewAlexander V van Schoonhoven, Judith J Gout-Zwart, Marijke J S de Vries, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Plos One|February 11, 2016

Cost-Analysis of Seven Nosocomial Outbreaks in an Academic HospitalJan-Willem H Dik, Ariane G Dinkelacker, Pepijn Vemer, et al.

Leukemia Research|September 23, 2016

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The NetherlandsHedwig M Blommestein, Saskia de Groot, Mieke J Aarts, et al.

Plos One|September 7, 2019

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic reviewAlexander V van Schoonhoven, Judith J Gout-Zwart, Marijke J S de Vries, et al.

Pageof 3